ArticlePLoS pathogens2025
Gut bacteria induce heterologous immune priming in Rhodnius prolixus encompassing both humoral and cellular immune responses.
Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Protocol for laboratory rearing and infection tracking of Rhodnius prolixus using 3D-printable designs.STAR protocols · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Insects lack the adaptive, antibody mediated responses of vertebrates, yet they possess a robust innate immune system capable of defending themselves against pathogens. Immune priming has been observed in multiple insect species, wherein exposure to a pathogen provides protection against subsequent infections by the pathogen. Heterologous immune priming has also been described, where presence of one bacterial species provides protection against another. We determined that Rhodococcus rhodnii, a gut symbiont of the kissing bug Rhodnius prolixus, induces strong heterologous immune priming, while axenic bugs lacking gut bacteria are highly susceptible to pathogens. Commensal Escherichia coli provides less robust protection. R. rhodnii must be alive within the insect as dead bacteria do not stimulate immune priming and pathogen resistance. Removal of R. rhodnii from the gut reduces resistance to pathogens while restoring it to axenic bugs improves pathogen resistance, though not completely. Unlike most other examples of symbiont-mediated immune priming, we find no evidence that R. rhodnii ever leaves the gut, despite activating a potent immune response in the hemocoel and fat body. R. rhodnii and E. coli activate both the IMD and Toll pathways indicating cross-activation of the pathways, while silencing of either pathway leads to a loss of the protective effect. Several antimicrobial peptides are induced in the fat body by presence of gut bacteria. When E. coli is in the gut, expression of antimicrobial peptides is often higher than when R. rhodnii is present, while R. rhodnii induces proliferation of hemocytes and induces a stronger melanization response than E. coli. Hemolymph from R. rhodnii bugs has a greater ability to convert the melanin precursor DOPA to melanization products than axenic or E. coli-harboring bugs. These results demonstrate that R. rhodnii's benefits to its host extend beyond nutritional provisioning, playing an important role in the host immune system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.